Gecko closes EUR 22.5M round

Gecko Biomedical S.A.S. (Paris, France) raised EUR 22.5 million ($25.1 million) in a series A2 round led by new investor Sofinnova Partners. Bpifrance also participated, as did existing investors Omnes Capital, CM-CIC Innovation and CapDecisif Management.

Gecko is developing sealants and adhesives for tissue repair based on biodegradable polymer technology. It is developing lead program GB-02 as a sealant for cardiovascular reconstruction. ...